The initial glycemic drop observed within the first hours corroborates findings from Palus et al. [13] and Wildermuth et al. [15], who reported that this dosage minimizes the risk of insulin-induced hypoglycemia while ensuring effective glucose suppression. This evidence concerns the gene INS and Hypoglycemia.